4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-122136
Chief Development Officer sold 11,767 shares at $36.01 ($423,730)
- Chief Development Officer acquired 11,767 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Guyer William Chief Development Officer | 2026-03-20 | Option exercise 10b5-1 | +11,767 | $21.65 | $254,756 | 13,998 | D: show line 1 in the form |
| Guyer William Chief Development Officer | 2026-03-20 | Sale 10b5-1 | −11,767 | $36.01 | $423,730 | 2,231 | D: show line 2 in the form |
| Open-market sales · 11,767 sh · avg $36.01 · $423,730 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Guyer William Chief Development Officer | 2026-03-20 | Option exercise · Stock Option (right to buy) 10b5-1 | −11,767 | 210,000 | D: show line 3 in the form |
Loading xslF345X06/ownership.xml…